Stock Price Forecast

May 10, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading ORAGENICS INC chart...

About the Company

We do not have any company description for ORAGENICS INC at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

18

Exchange

NYSE

$15M

Total Revenue

18

Employees

$6M

Market Capitalization

-0.75

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $OGEN News

Oragenics, Inc. (OGEN)

1d ago, source: Yahoo Finance

SARASOTA, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneer in developing innovative intranasal pharmaceuticals for neurological disorders, today announced a ...

Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

22d ago, source: Morningstar

Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice ...

Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia

4d ago, source: Business Insider

SARASOTA, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneer in developing innovative intranasal pharmaceuticals for neurological disorders, today announced a ...

Oragenics, Inc. Files 10K and Provides Company Update

1mon ago, source: Stockhouse

Oragenics, Inc. (the “Company”) (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today ...

Oragenics, Inc. (OGEN) Interactive Stock Chart - Yahoo Finance

22d ago, source: Yahoo Finance

SARASOTA, Fla., April 19, 2024--Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced ...

Oragenics, Inc.

5mon ago, source: CNN

Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug ...

Oragenics, Inc. (OGEN)

15d ago, source: Yahoo Finance

SARASOTA, Fla., April 19, 2024--Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today ...

Oragenics Inc

25d ago, source: U.S. News & World Report

Semiconductor ETFs can help investors tap into tailwinds such as demand from artificial intelligence, government grants and a re-shoring movement. For most investors, the best investment strategy ...

Oragenics, Inc. (OGEN)

3mon ago, source: Yahoo Finance

SARASOTA, Fla., April 19, 2024--Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...